ReviewFrontiers in bioengineering and biotechnology2025
Recent progress of polydopamine nanoparticles as advanced antimicrobial nanomaterials.
Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Melanin-like Materials for Photothermal Applications: Recent Advancements and Future Directions.Molecules (Basel, Switzerland) · 2026Review
- From structural complexity to circular applications: a comparative review of the enzymatic degradation of polydopamine, tannins, lignins, and melanins.RSC advances · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global rise of antimicrobial resistance has driven the search for novel antimicrobial strategies with higher effectiveness than common antibiotics. Among various solutions, polydopamine nanoparticles (PDA NPs) have gained widespread attention owing to their biocompatibility, functional versatility, and responsiveness to environmental stimuli. This review summarizes recent advances in the synthesis, functionalization, and antimicrobial applications of PDA NPs, highlighting their potential as smart nanomaterials. PDA NPs exhibit intrinsic antimicrobial activity, large drug delivery capabilities, and excellent photothermal properties. Moreover, they can potentially eradicate biofilms; can be synergistically combined with other entities such as metal ions, antimicrobial peptides, and Fenton-like catalysts; and can provide
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.